Thu, February 16, 2012
Wed, February 15, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Biogen Idec adquiere Stromedix
Tue, February 14, 2012
Mon, February 13, 2012
Sun, February 12, 2012
Fri, February 10, 2012
Thu, February 9, 2012
Wed, February 8, 2012
[ Wed, Feb 08th 2012 ] - Market Wire
Imaging3 Updates Website
Tue, February 7, 2012
Mon, February 6, 2012

BD to Present at Investor Healthcare Conferences


//health-fitness.news-articles.net/content/2012/ .. -present-at-investor-healthcare-conferences.html
Published in Health and Fitness on Friday, February 10th 2012 at 11:06 GMT by Market Wire   Print publication without navigation


BD to Present at Investor Healthcare Conferences -- FRANKLIN LAKES, N.J., Feb. 10, 2012 /PRNewswire/ --

BD to Present at Investor Healthcare Conferences

[ ]

FRANKLIN LAKES, N.J., Feb. 10, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: [ BDX ]), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2012:

Leerink Swann 2012 Global Healthcare Conference
February 15, 2012
10:30 a.m. ET

Citi 2012 Global Healthcare Conference
February 28, 2012
10:00 a.m. ET

Live webcasts of BD's presentations can be accessed on the BD corporate website at [ www.bd.com/investors ].  They will be available for replay for a period of seven days after each conference.  

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit [ www.bd.com ].

Contact:
Monique N. Dolecki, Investor Relations – 201-847-5378
Colleen T. White, Corporate Communications – 201-847-5369

SOURCE BD (Becton, Dickinson and Company)

[ Back to top ]

RELATED LINKS
[ http://www.bd.com ]


Publication Contributing Sources